Vertex Pharmaceuticals Inc
F:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
F:VX1
|
US |
|
V
|
Vanquis Banking Group PLC
SWB:PRVA
|
UK |
|
Canadian Natural Resources Ltd
TSX:CNQ
|
CA |
Multiples-Based Value
The Multiples-Based Value for
Vertex Pharmaceuticals Inc (VX1) under the Base Case is 364.83 EUR.
Compared with the current market price of 410.9 EUR, the stock appears
Overvalued by 11% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.